Update
Injective Rallies 10%
Injective has rallied 10% after a strong five-day recovery. Fresh optimism followed a new partnership announcement with Gulf Labs, which joined the network as an institutional validator. This development strengthens network security and expands participation in governance activities, adding to the market's improving outlook. Trading volume has also increased, suggesting stronger participation from traders and investors, which often supports bullish momentum.